Full Text View
Tabular View
No Study Results Posted
Related Studies
Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant (VICTA)
This study is currently recruiting participants.
Study NCT00078533   Information provided by Baylor College of Medicine
First Received: March 1, 2004   Last Updated: January 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stem Cell Transplantation
Cytomegalovirus Infections
Additional conditions recognized in this trial
Infection
More general conditions related to this trial
DNA Virus Infections
Herpesviridae Infections
Virus Diseases
Interventions listed in this trial
CMV CTL infusion
Sponsors listed in this trial
Baylor College of Medicine
The Methodist Hospital System
Texas Children's Hospital
Center for Cell and Gene Therapy


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services